Answer
The FDA, or Food and Drug Administration, withdrew approval for Glycel, a drug used to treat hyperglycemia in people with type 2 diabetes. The FDA's decision was based on a review of data that showed that Glycel was not effective in controlling blood sugar levels and may increase the risk of heart failure.